CAN Cann Group Limited
Healthcare · Drug Manufacturers - Specialty & Generic
· website
$0.00
52wk 0.00 – 0.02
Overall
58.8
Value
100.0
Growth
61.7
Health
49.4
Quality
54.5
Momentum
16.9
Dividend
—
Price
About Cann Group Limited
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.
Price analytics
Returns
| 1 day | -11.1% |
| 1 week | -20.0% |
| 1 month | -20.0% |
| 3 months | 0.0% |
| 6 months | -20.0% |
| 1 year | -71.4% |
| 3 years | -96.7% |
Risk
| Volatility (1y ann.) | 213.5% |
| Beta vs ASX 200 | 0.16 |
| Sharpe (1y) | 0.22 |
| VaR 95% (1-day) | -16.7% |
| Max drawdown (1y) | -87.1% |
| Off 1-year high | -74.2% |
Technicals
| RSI(14) | 40 |
| vs 50DMA | 3.4% |
| vs 200DMA | -28.3% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
100.0
Trailing P/E
100
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
100
Price / Sales
100
Growth
61.7
Revenue growth (1y)
62
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
49.4
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
11
Debt / Equity
80
Quality (Profitability & Cash Flow)
54.5
Return on equity
100
Return on assets
0
Operating margin
0
Net margin
100
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
16.9
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
67
Position in 52-week range
13
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$7.47M
P/E (trailing)
0.23
P/E (forward)
0.01
EPS (trailing)
0.02
Dividend yield
—
Payout ratio
0.0%
Beta
0.11
EV / EBITDA
-4.61
Price / Book
0.25
ROE
154.5%
Operating margin
-96.0%
Net margin
210.4%
Total cash
$490,000
Total debt
$16.39M
Current ratio
0.99
Debt / Equity
0.56
Free cash flow
$642,125
Avg volume
3.37M
Latest annual results
(FY ending 30 Jun 2026)
- Revenue—
- Gross profit—
- Operating income—
- Net income—
- Diluted EPS0.02
- Free cash flow—
- Net debt—